Immunoassay Services

Expert Immunoassay solutions to progress your clinical research pipelines.

Immunoassay Bioanalytical Solutions

Immunoassays are a fundamental tool for the development of large-molecule biotherapeutics, enabling sensitive and specific quantification of drug levels in clinical samples. Successful PK assay development begins with selecting the right immunochemically relevant tools to generate a sensitive, robust quantitative bioanalytical method suitable for use in analysis of samples derived from clinical trials.

At Synexa, we develop and validate bespoke immunoassays to support PK analysis of complex biologics, ensuring high-quality data for confident decision-making. All assays are developed adhering to current guidelines, ensuring compliance with GCP/GLP regulatory requirements.

Immunoassay Services

Clinical Bioanalysis

Custom-developed, GCP-compliant Ligand-binding assays for PK, ADA, and biomarker analysis, fully validated with long-term stability testing.

GLP Bioanalysis

GLP-compliant bioanalysis for preclinical studies, from MTD to pivotal toxicology, supporting seamless transition to clinical development.

Anti Drug Antibody (ADA)

ADA assay development, validation and clinical sample analysis to assess immune responses to biologics and support safety and efficacy evaluations.

Our Bioanalytical Platforms

Our technology platforms are robust, reliable and reputable in the clinical field and provide comprehensive and detailed data readouts for your application.